Discovery and Characterization of Inhibitors of Pseudomonas aeruginosa Type III Secretion
- 1 May 2010
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (5), 1988-1999
- https://doi.org/10.1128/aac.01598-09
Abstract
The type III secretion system (T3SS) is a clinically important virulence mechanism in Pseudomonas aeruginosa that secretes and translocates up to four protein toxin effectors into human cells, facilitating the establishment and dissemination of infections. To discover inhibitors of this important virulence mechanism, we developed two cellular reporter assays and applied them to a library of 80,000 compounds. The primary screen was based on the dependence of the transcription of T3SS operons on the T3SS-mediated secretion of a negative regulator and consisted of a transcriptional fusion of the Photorhabdus luminescens luxCDABE operon to the P. aeruginosa exoT effector gene. Secondary assays included direct measurements of the T3SS-mediated secretion of a P. aeruginosa ExoS effector-β-lactamase fusion protein as well as the detection of the secretion of native ExoS by the sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis of culture supernatants. Five inhibitors in three chemical classes were demonstrated to inhibit type III secretion selectively with minimal cytotoxicity and with no effects on bacterial growth or on the type II-mediated secretion of elastase. These inhibitors also block the T3SS-mediated secretion of a YopE effector-β-lactamase fusion protein from an attenuated Yersinia pestis strain. The most promising of the inhibitors is a phenoxyacetamide that also blocks the T3SS-mediated translocation of effectors into mammalian cells in culture. Preliminary studies of structure-activity relationships in this phenoxyacetamide series demonstrated a strict requirement for the R -enantiomer at its stereocenter and indicated tolerance for a variety of substituents on one of its two aromatic rings.Keywords
This publication has 57 references indexed in Scilit:
- The type III secretion system of Pseudomonas aeruginosa: infection by injectionNature Reviews Microbiology, 2009
- Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies*Critical Care Medicine, 2009
- The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesisNature Immunology, 2009
- Cellular reporter screens for inhibitors of Burkholderia pseudomallei targets in Pseudomonas aeruginosaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2008
- An Inhibitor of Gram-Negative Bacterial Virulence Protein SecretionCell Host & Microbe, 2008
- Pseudomonas aeruginosa activates caspase 1 through IpafProceedings of the National Academy of Sciences of the United States of America, 2008
- Salicylidene Acylhydrazides That Affect Type III Protein Secretion inSalmonella entericaSerovar TyphimuriumAntimicrobial Agents and Chemotherapy, 2007
- A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatisProceedings of the National Academy of Sciences of the United States of America, 2006
- Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycleMolecular Microbiology, 2006
- Bioinformatics, genomics and evolution of non-flagellar type-III secretion systems: a Darwinian perpectiveFEMS Microbiology Reviews, 2005